Schedule 13G ownership disclosure

CIDARA THERAPEUTICS INC

Common Stock · CUSIP: 171757206

Event date: 2025-12-31

Filing-level shares
2,007,193
Percent of class
6.38%
  • The Vanguard Group

    Shares: 2,007,193 · Class: 6.38%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000102909-26-000047
Form type
SCHEDULE 13G
Filer
Cidara Therapeutics, Inc.
CIK
CIK 1610618
Filed
Jan 30, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub